Gelinck, L.B.S.

patient vaccination study vaccine group influenza response hiv-infected patients hiv-infected control serum antibody titer level disease intradermal fluenza adomet anti-tnf b-d-glucan fluenza vaccination infection ph 1n virus effect pneumocystis subject influenza vaccination therapy intradermal vaccination treatment pneumonia sample diagnosis atovaquone baseline ph 1n vaccine article pneumocystis pneumonia netherland pneumococcal count raltegravir center s-adenosylmethionine /ritonavir concentration 2009 pandemic influenza university protection immunocompromized patients plasma antiretroviral lopinavir /ritonavir intramuscular pandemic population s-adenosylmethionine serum levels table cancer immunode ficiency virus pneumocystis carinii pneumonia strain immunode factor antigen leiden university 2009–2010 intramuscular vaccination ficiency anti-tnf group protection rates department result serotype leiden efavirenz pharmacokinetic seroprotection rate study groups